Answers are grounded in this paper and cite their sources.
In the second edition of the Huntington’s Disease Clinical Trials Corner we list all currently registered and ongoing clinical trials, summarise the top-line results of the recently-announced IONIS-HTTRX trial (NCT02519036), expand on Wave Life Sciences’ PRECISION-HD1 (NCT03225833) and PRECISION-HD2 (NCT03225846), and cover one recently finished trial: the FIRST-HD deutetrabenazine trial (NCT01795859).
No takes yet. Share an insight, caveat, or question.
Rodrigues et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: